Optimization of incubation temperature in embryonated chicken eggs inoculated with H9N2 vaccinal subtype of avian influenza virus

Authors

  • Ali Ameghi Department of Research and Development, Razi Vaccine and Serum Research Institute, Marand, Iran
  • Iraj Khalili Department of Research and Development, Razi Vaccine and Serum Research Institute, Marand, Iran
  • Rahim Ghadimipour Department of Research and Development, Razi Vaccine and Serum Research Institute, Marand, Iran
  • Saeed Sedigh-Eteghad Department of Research and Development, Razi Vaccine and Serum Research Institute, Marand, Iran
Abstract:

There are little information about growth properties of low pathogenic (LP) avian influenza virus (AIV) in embryonated chicken eggs (ECEs) at different incubation temperatures. Knowledge of this information increases the quantity and quality of antigen in vaccine production process. For this purpose, 10-5 dilution of AIV (A/Chicken/Iran/99/H9N2) was inoculated (Intra-allantoic) into 400, 11-day old specific pathogen free (SPF) ECEs in the 0.1 mL per ECE rate and incubated in 32, 33, 34, 35, 36, 37.5, 38, 39 ˚C for 72 hr in 65% humidity. Early death embryos in first 24 hr were removed. Amnio-allantoic fluid was withdrawn into the measuring cylinder, and tested for hemagglutination (HA) activity and egg infective dose 50 (EID50). The utilizable ECEs and amnio-allantoic fluid volume was significantly increased in 35 ˚C, (p < 0.05). Significant difference in HA and EID50 titers, were seen only in 39 ˚C group. Therefore, 35°C is an optimum temperature for incubation of inoculated ECEs.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

optimization of incubation temperature in embryonated chicken eggs inoculated with h9n2 vaccinal subtype of avian influenza virus

there are little information about growth properties of low pathogenic (lp) avian influenza virus (aiv) in embryonated chicken eggs (eces) at different incubation temperatures. knowledge of this information increases the quantity and quality of antigen in vaccine production process. for this purpose, 10-5 dilution of aiv (a/chicken/iran/99/h9n2) was inoculated (intra-allantoic) into 400, 11-day...

full text

Monitoring virus harvesting time in embryonated chicken eggs inoculated with avian influenza H9N2 vaccine strain

Knowledge of virus and replication kinetic is one of the most important issues in the vaccine production. The present study aimed to evaluate the best harvesting time of H9N2 avian influenza virus (AIV) vaccine strain inoculated in specific pathogen free (SPF) embryonated chicken eggs (ECE)s. For this purpose, 10-5 dilution of AIV (A/Chicken/Iran/99/H9N2) was inoculated into 336, 11-day old ECE...

full text

monitoring virus harvesting time in embryonated chicken eggs inoculated with avian influenza h9n2 vaccine strain

knowledge of virus and replication kinetic is one of the most important issues in the vaccine production. the present study aimed to evaluate the best harvesting time of h9n2 avian influenza virus (aiv) vaccine strain inoculated in specific pathogen free (spf) embryonated chicken eggs (ece)s. for this purpose, 10-5 dilution of aiv (a/chicken/iran/99/h9n2) was inoculated into 336, 11-day old ece...

full text

Evolution of H9N2 avian influenza virus in embryonated chicken eggs with or without homologous vaccine antibodies

BACKGROUND Vaccines constitute a unique selective pressure, different from natural selection, drives the evolution of influenza virus. In this study, A/Chicken/Shanghai/F/1998 (H9N2) was continually passaged in specific pathogen-free embryonated chicken eggs with or without selective pressures from antibodies induced by homologous maternal antibodies. Genetic mutations, antigenic drift, replica...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 4  issue 3

pages  145- 148

publication date 2013-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023